Adoptive T cell immunotherapy for cytomegalovirus

The Effect of Single and Combined Activating Killer Immunoglobulin-like Receptor Genotypes on Cytomegalovirus Infection and Immunity after Hematopoietic Cell Transplantation

(2009) John A. Zaia et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy

(2009) Yuriko Fujita et al.   JOURNAL OF IMMUNOTHERAPY

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study

(2008) D. J. Winston et al.   BLOOD

Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation

(2008) K. P. Micklethwaite et al.   BLOOD

Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations

(2008) Jan W. Gratama et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Cytomegalovirus and human immunosenescence

(2008) Graham Pawelec et al.   REVIEWS IN MEDICAL VIROLOGY

Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells

(2007) Stephen Mackinnon et al.   BLOOD CELLS MOLECULES AND DISEASES